SQSTM1 and hepatocellular carcinoma: Furthermore, among 93 human HCC cases, 36 cases of co-high expression of p62 and Sirt1 exhibited significantly shorter overall survival than 35 cases of co-low expression (Fig. 7B; p < 0.05), demonstrating the relevance of Sirt1-p62 axis to HCC.